Cunningham Ann Michelle
SEC insider (Form 3/4/5 filer). CIK 0001764572. Director at ALTERITY THERAPEUTICS LTD (ATHE) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2025. Located in SOUTH SAN FRANCISCO, CA.
Companies Cunningham Ann Michelle has filed insider reports for
- ALTERITY THERAPEUTICS LTD (ATHE): Director
- Vistagen Therapeutics, Inc. (VTGN): Director
Cunningham Ann Michelle
CIK: 0001764572
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
